Jiangsu Topfly New Materials (001373.SZ) issued a pre-announcement, expecting a year-on-year decrease in net profit of 56.01%-65.94% for the year 2024.
Xiangteng New Materials (001373.SZ) released its performance forecast for the year 2024, with an estimated full-year net profit attributable to shareholders of the listed company...
Jiangsu Topfly New Materials (001373.SZ) has released its performance forecast for 2024, expecting a net profit attributable to shareholders of the listed company of 12-15.5 million yuan, a year-on-year decrease of 56.01%-65.94%. During the reporting period, the company's sales revenue and gross profit margin have decreased due to intensified competition in the industry and strategic adjustments in some downstream customers' industries. Faced with increasingly fierce industry competition, the company continues to focus on its core business, actively exploring the market, developing new customers, and increasing sales expenses during the reporting period.
Related Articles

Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.

CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.

On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.

CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.

On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.

RECOMMEND

General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025

Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025

Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025